Companies: 10,795·Total market cap: $144.5T
Nurix Therapeutics, Inc.

Nurix Therapeutics, Inc.

NRIXNASDAQHealthcare● Active
$15.64
+$1.00(+6.83%)
Market Cap$1.4B
P/E Ratio
52W High$22.5
52W Low$8.195
Overview

Nurix Therapeutics, Inc. (NRIX) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · NRIX · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-3.16nrix eps ttm · nrix earnings per shareEarnings history
PE Ratio (TTM)nrix pe ratio ttm · nrix price to earningsPE Ratio deep dive
Revenue (TTM)$71.8Mnrix revenue ttm · nrix annual revenueFull revenue history
Dividend YieldNo Dividenddoes nrix pay dividends · nrix dividend yieldDividend history
Shares Outstanding86.7Mnrix shares outstanding · nrix floatShares outstanding history
Next EarningsJul 9, 2026Est.nrix earnings date · nrix next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$84.0M▲ +53.95% YoY
202320242025
nurix therapeutics, inc. revenue · nrix revenue 2025
FY 2025Net Income-$264.5M▼ 36.62% YoY
202320242025
nurix therapeutics, inc. net income · nrix profit 2025
FY 2025EPS$-3.05▼ 5.90% YoY
202320242025
nrix eps · nurix therapeutics, inc. earnings per share 2025
TTM:Revenue: $71.8MNet Income: -$295.3MEPS: $-3.16View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy17 analystsis nrix a buy · nrix analyst rating
Strong Buy
0
Buy
17
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$28.00Low
$15.64Current
$34.00Avg Target117.39% upside
$45.00High
nrix price target · nrix 12 month forecast

Total: 17 · Buy rate: 100.0%

The NRIX analyst consensus is Buy, based on ratings from 17 Wall Street analysts over the past 3 months. The average 12-month price target is $34.00, representing +117.39% upside from the current price of $15.64.

Stock Performance

Full History
1D+6.83%
1W-4.11%
1M-5.33%
3M+3.58%
YTD-17.55%
1Y+24.72%
5Y-50.51%

About Nurix Therapeutics, Inc.

CEOArthur T. Sands
IPO DateJul 24, 2020
Employees286
CountryUS

Nurix Therapeutics, Inc. a biopharmaceutical firm headquartered in San Francisco, California, was founded in 2009. This company, which rebranded from Nurix Inc. in October 2018, is dedicated to the i…

what is nurix therapeutics, inc. · nrix stock overview · nurix therapeutics, inc. company profile · who is nurix therapeutics, inc. ceo · nrix NASDAQ · nurix therapeutics, inc. headquarters · nurix therapeutics, inc. business segments

About Stock Overview & Key Data

Nurix Therapeutics, Inc. (NRIX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 24, 2020. As of the latest trading session, NRIX stock price is $15.64, with a market capitalization of $1.4B. The stock has returned +24.72% over the past 12 months and -17.55% year-to-date.

According to 17 Wall Street analysts, the consensus rating for Nurix Therapeutics, Inc. stock is Buy, with an average 12-month price target of $34.00. In fiscal year 2025, Nurix Therapeutics, Inc. reported revenue of $84.0M and net income of -$264.5M. For detailed data — including Nurix Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Nurix Therapeutics, Inc. (NRIX) stock price is $15.64. The stock is traded on NASDAQ under the ticker symbol NRIX. The 52-week range is $8.20 – $22.50.

NRIX stock priceNRIX quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice